Federation des caisses Desjardins du Quebec
LTRN icon

Federation des caisses Desjardins du Quebec’s Lantern Pharma LTRN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-800
Closed -$2.53K – 2948
2025
Q2 		$2.53K Buy
+800
New +$2.7K ﹤0.01% 2379

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
NewEdge Advisors
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's LTRN Position: Q3 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Lantern Pharma (LTRN) in Q3 2025, closing a stake of 800 shares — an estimated $2.53K sold.

Federation des caisses Desjardins du Quebec first reported a position in LTRN in Q2 2025 and held it in 1 quarter. The position peaked at $2.53K in Q2 2025. 30 funds tracked by Wall St. Rank hold LTRN as of Q3 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Lantern Pharma position as of Q3 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 800 Lantern Pharma shares in Q3 2025, an estimated $2.53K.
  • Federation des caisses Desjardins du Quebec first reported a position in Lantern Pharma in Q2 2025 and held it in 1 quarter.
  • Federation des caisses Desjardins du Quebec's Lantern Pharma position peaked at $2.53K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.